High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households

Matthieu Fritz(Centre National de la Recherche Scientifique), Béatrice Rosolen, Émilie Krafft(Université Claude Bernard Lyon 1), Pierre Becquart(Centre National de la Recherche Scientifique), Éric Elguero(Centre National de la Recherche Scientifique), Oxana Vratskikh(Institut Pasteur), Solène Denolly(Université Claude Bernard Lyon 1), Bertrand Boson(Université Claude Bernard Lyon 1), Jessica Vanhomwegen(Institut Pasteur), Meriadeg Ar Gouilh(Normandie Université), Angéli Kodjo(Université Claude Bernard Lyon 1), Catherine Chirouze(Université de Bourgogne), Serge G. Rosolen(Centre National de la Recherche Scientifique), Vincent Legros(Université Claude Bernard Lyon 1), Eric M. Leroy(Centre National de la Recherche Scientifique)
One Health
November 5, 2020
Cited by 204Open Access
Full Text

Abstract

In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.


Related Papers

No related papers found

Powered by citation graph analysis